Ontology type: schema:ScholarlyArticle Open Access: True
2014-06-26
AUTHORS ABSTRACTNesiritide and dopamine have been recognized for some time as potential renal adjunct therapies in the management of patients with acute heart failure (AHF). Several studies have yielded conflicting evidence of the efficacy of both medications in enhancing the renal function of patients with AHF. The Renal Optimization Strategies Evaluation (ROSE) study was a multicenter double-blind placebo controlled trial designed to assess the potential renoprotective effects of low-dose nesiritide and dopamine in AHF patients with renal dysfunction. This article will focus on previous research, summary of results, and lessons learned from the ROSE-AHF trial as well as future directions for clinical research and applications. More... »
PAGES260-265
http://scigraph.springernature.com/pub.10.1007/s11897-014-0208-6
DOIhttp://dx.doi.org/10.1007/s11897-014-0208-6
DIMENSIONShttps://app.dimensions.ai/details/publication/pub.1043129398
PUBMEDhttps://www.ncbi.nlm.nih.gov/pubmed/24966060
JSON-LD is the canonical representation for SciGraph data.
TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT
[
{
"@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json",
"about": [
{
"id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11",
"inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/",
"name": "Medical and Health Sciences",
"type": "DefinedTerm"
},
{
"id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1102",
"inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/",
"name": "Cardiorespiratory Medicine and Haematology",
"type": "DefinedTerm"
},
{
"id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1103",
"inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/",
"name": "Clinical Sciences",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Acute Kidney Injury",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Disease Progression",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Dose-Response Relationship, Drug",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Heart Failure",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Humans",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Natriuretic Agents",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Natriuretic Peptide, Brain",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Stroke Volume",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Treatment Outcome",
"type": "DefinedTerm"
}
],
"author": [
{
"affiliation": {
"alternateName": "Department of Internal Medicine, Mayo Clinic and Foundation, Rochester, MN, USA",
"id": "http://www.grid.ac/institutes/grid.66875.3a",
"name": [
"Department of Internal Medicine, Mayo Clinic and Foundation, Rochester, MN, USA"
],
"type": "Organization"
},
"familyName": "Jain",
"givenName": "Amit K.",
"id": "sg:person.01357346364.14",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01357346364.14"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "Division of Cardiovascular Diseases, Mayo Clinic and Foundation, 200 First Street SW, 55905, Rochester, MN, USA",
"id": "http://www.grid.ac/institutes/grid.66875.3a",
"name": [
"Division of Cardiovascular Diseases, Mayo Clinic and Foundation, 200 First Street SW, 55905, Rochester, MN, USA"
],
"type": "Organization"
},
"familyName": "Chen",
"givenName": "Horng H.",
"id": "sg:person.01024326700.50",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01024326700.50"
],
"type": "Person"
}
],
"citation": [
{
"id": "sg:pub.10.1016/s0009-9236(97)90067-9",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1047412212",
"https://doi.org/10.1016/s0009-9236(97)90067-9"
],
"type": "CreativeWork"
},
{
"id": "sg:pub.10.1038/clpt.2013.136",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1019834567",
"https://doi.org/10.1038/clpt.2013.136"
],
"type": "CreativeWork"
}
],
"datePublished": "2014-06-26",
"datePublishedReg": "2014-06-26",
"description": "Nesiritide and dopamine have been recognized for some time as potential renal adjunct therapies in the management of patients with acute heart failure (AHF). Several studies have yielded conflicting evidence of the efficacy of both medications in enhancing the renal function of patients with AHF. The Renal Optimization Strategies Evaluation (ROSE) study was a multicenter double-blind placebo controlled trial designed to assess the potential renoprotective effects of low-dose nesiritide and dopamine in AHF patients with renal dysfunction. This article will focus on previous research, summary of results, and lessons learned from the ROSE-AHF trial as well as future directions for clinical research and applications.",
"genre": "article",
"id": "sg:pub.10.1007/s11897-014-0208-6",
"inLanguage": "en",
"isAccessibleForFree": true,
"isFundedItemOf": [
{
"id": "sg:grant.2437014",
"type": "MonetaryGrant"
},
{
"id": "sg:grant.2540938",
"type": "MonetaryGrant"
}
],
"isPartOf": [
{
"id": "sg:journal.1033049",
"issn": [
"1546-9530",
"1546-9549"
],
"name": "Current Heart Failure Reports",
"publisher": "Springer Nature",
"type": "Periodical"
},
{
"issueNumber": "3",
"type": "PublicationIssue"
},
{
"type": "PublicationVolume",
"volumeNumber": "11"
}
],
"keywords": [
"acute heart failure",
"multicenter double-blind placebo",
"ROSE-AHF trials",
"double-blind placebo",
"management of patients",
"potential renoprotective effects",
"AHF patients",
"ROSE-AHF",
"renal function",
"renoprotective effects",
"renal dysfunction",
"adjunct therapy",
"heart failure",
"clinical research",
"patients",
"trials",
"dopamine",
"placebo",
"medications",
"evaluation study",
"dysfunction",
"therapy",
"efficacy",
"study",
"future directions",
"failure",
"evidence",
"management",
"summary",
"summary of results",
"effect",
"previous research",
"function",
"research",
"time",
"lessons",
"results",
"article",
"direction",
"applications"
],
"name": "ROSE-AHF and Lessons Learned",
"pagination": "260-265",
"productId": [
{
"name": "dimensions_id",
"type": "PropertyValue",
"value": [
"pub.1043129398"
]
},
{
"name": "doi",
"type": "PropertyValue",
"value": [
"10.1007/s11897-014-0208-6"
]
},
{
"name": "pubmed_id",
"type": "PropertyValue",
"value": [
"24966060"
]
}
],
"sameAs": [
"https://doi.org/10.1007/s11897-014-0208-6",
"https://app.dimensions.ai/details/publication/pub.1043129398"
],
"sdDataset": "articles",
"sdDatePublished": "2022-05-10T10:10",
"sdLicense": "https://scigraph.springernature.com/explorer/license/",
"sdPublisher": {
"name": "Springer Nature - SN SciGraph project",
"type": "Organization"
},
"sdSource": "s3://com-springernature-scigraph/baseset/20220509/entities/gbq_results/article/article_621.jsonl",
"type": "ScholarlyArticle",
"url": "https://doi.org/10.1007/s11897-014-0208-6"
}
]Download the RDF metadata as: json-ld nt turtle xml License info
JSON-LD is a popular format for linked data which is fully compatible with JSON.
curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/s11897-014-0208-6'
N-Triples is a line-based linked data format ideal for batch operations.
curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/s11897-014-0208-6'
Turtle is a human-readable linked data format.
curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/s11897-014-0208-6'
RDF/XML is a standard XML format for linked data.
curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/s11897-014-0208-6'
This table displays all metadata directly associated to this object as RDF triples.
163 TRIPLES
22 PREDICATES
77 URIs
66 LITERALS
16 BLANK NODES